Systemic estrogen is the most effective treatment for hot flashes and night sweats. Estrogen can alleviate vaginal symptoms of. HRT involves taking estrogen and progestogen (combined HRT) or simply taking estrogen (estrogen-only HRT). Estrogen patches are generally considered to be the safest form of estrogen hormone therapy, especially if you're over 35 or smoke, as they're less likely to cause clots blood levels than estrogen pills.
Systemic estrogen therapy (with or without progestin) has proven to be the best treatment for hot flashes and night sweats. Both systemic and local estrogen therapy alleviate vaginal dryness. According to the analysis carried out by the World Health Organization on life expectancy in 35 countries of the Organization for Economic Cooperation and Development (OECD), life expectancy in South Korea is expected to rank first in the world in 2030, and that women's life expectancy will reach 90.82 years. In other words, the importance of women's health and quality of life (CV) after menopause goes on the rise.
The most effective treatment for vasomotor symptoms (VMS) and genitourinary menopausal syndrome (GSM) is menopausal hormone therapy (MHT), which is also effective in preventing osteoporosis. Hormonal hormone therapy is an effective therapy that offers more advantages than disadvantages for women under 60 years of age or who have been menopausal for less than 10 years. Therefore, the purpose of these guidelines is to provide help by sharing knowledge and precise treatment methods related to hormone therapy based on recent research findings. Breast cancer was seen to relapse in 15.2% of patients in the tibolone treatment groups (237 out of 1,556 patients) and 10.7% of patients (165 out of 1,542 people) in the placebo group, and there was a 1.4-fold increase in incidence of breast cancer when tibolone was taken.
Therefore, tibolone should not be used in patients with breast cancer. National Library of Medicine 8600 Rockville Pike Bethesda, MD 20894. There is no need to impose a limit on the duration of hormone therapy as long as a minimum effective dose is used, if women are well aware of the potential benefits and risks, and if they are accompanied by regular clinical monitoring. Since VMS occurs in connection with the reduction of estrogen levels in the central nervous system, MHT is the most effective treatment. Deep vein thrombosis (DVT) The combination of hormone therapy and estrogen-only therapy is associated with a low risk of stroke and blood clot formation due to thrombosis deep vein.
The incorrect application of the results of a well-designed clinical trial (the WHI trial) to populations and hormone formulations not included in the study has caused many women to experience untreated menopausal symptoms and widespread confusion among doctors about the real risks and benefits of different hormone therapies. It is taken to replace the estrogen that the body stops producing after menopause, which is when periods stop for good. These hormones are primarily estrogen and progestogen, which are essential for everything from menstrual cycles, ovulation, and pregnancy to bone health. When counseling patients who are going through menopause, doctors should understand the benefits and risks of hormone therapy, hormone-free prescription medications, and alternative treatments, and be familiar with each other with the different methods of administration.
Therefore, women who are relatively older or who have spent a lot of time since menopause (average age, 63.2 years) in the WHI study may not have experienced any significant effect on cardiovascular protection due to hormone therapy like women in early menopause who are in good cardiovascular health. Tibolone has no biological activation by itself, but since its metabolites show particular medicinal effects depending on human tissue, it is classified as a selective regulator of tissue estrogenic activity. If a patient prefers a bioidentical hormone, she may consider taking FDA-approved medications containing the bioidentical hormone estradiol; for women with a uterus, micronized progestogen (100 mg or 200 mg per day) must be added. The decision to use hormone therapy depends on the clinical presentation, a thorough evaluation of the risks and benefits, and an informed conversation with the patient.
In addition, measuring follicle-stimulating hormone levels after discontinuing oral contraceptives may be inaccurate during perimenopause. Measuring the serum level of a sex hormone doesn't help much in diagnosing and treating sexual dysfunction, and a blood test for testosterone is not recommended to diagnose androgen deficiency in healthy women.
